re: Ann: MLA delivers 18% increase in half ye... Correct - this stock is a "no brainer" - I'll be happy to sit back and enjoy the ride this year.
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial